PNPLA3 and obesity due to melanocortin 4 receptor deficiency: In fact, our longitudinal investigation allowed us to describe how the evolution of the PNPLA3-associated phenotype incorporates the involvement of signs and symptoms beyond the liver, such as obesity, while other parameters might be within normal ranges thanks to the therapeutic regimen.